Sands Capital's position in Dexcom is currently worth $948 Million. That's 2.84% of their equity portfolio (15th largest holding). The investor owns 2.96% of the outstanding Dexcom stock. The first Dexcom trade was made in Q1 2020. Since then Sands Capital bought shares ten more times and sold shares on nine occasions. The investor's estimated purchase price is $1.04 Billion, resulting in a loss of 9.1%.
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” fourth quarter 2023 investor letter....
Hedge Fund Carlson Shrinks To One Office After Assets Fall 90% (Bloomberg) Hong Kong Investor Files Court Injunction On NEC’s JAE Stake Sale (The Business Ti...
… the period. Capital World Investors ’ holdings in DexCom were … funds and other institutional investors have also recently added … stock is owned by instit...
Brinker Capital Investments LLC trimmed its position in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 4.0% during the 4th quarter, HoldingsChannel rep...